Jing-Tyan Ma

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies.

E. Blasi, T. Smeal, M. Spilker, 2014, Blood advances.

Decoy receptor 3 alleviates hepatic fibrosis through suppressing inflammation activated by NF-κB signaling pathway.

Q. Zhan, Siqi Liu, Jing-Tyan Ma, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection

Wudong Wang, Jing-Tyan Ma, Xue Shao, 2017, Front. Cell. Infect. Microbiol..

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

M. Dorywalska, A. Rajpal, P. Strop, 2019, Scientific Reports.

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

M. Dorywalska, A. Rajpal, P. Strop, 2019, Scientific Reports.

Abstract 601: IO-108, A fully human therapeutic antibody blocking the myeloid checkpoint LILRB2/ILT4, promotes innate and adaptive anti-cancer immunity in preclinical studies

C. Zhang, P. Woodard, Xiaoye Liu, 2022, Cancer Research.